Concepedia

Yuqiao Shen

YS

Statistics

Publications

32

Citations

3.5K

H-Index

24

Active since

1993

Affiliations

BioMarin (United States)(Current)

Tsinghua University

Institut National de Physique Nucléaire et de Physique des Particules

Centre National de la Recherche Scientifique

Chinese Academy of Sciences

Yuqiao Shen is an author at BioMarin (United States) specializing in oncology, natural sciences, and pharmacology.

ORCID

Publications per year

1993–2021

32

Publications

32

BMN 673, a Novel and Highly Potent PARP1/2 Inhibitor for the Treatment of Human Cancers with DNA Repair Deficiency

Yuqiao Shen, Farah Rehman, Ying Feng et al. · Clinical Cancer Research · 2013 · 487 citations · Full text

, , +14

Late viral RNA export, rather than p53 inactivation, determines ONYX-015 tumor selectivity

Clodagh C. O’Shea, Leisa Johnson, Bridget Bagus et al. · Cancer Cell · 2004 · 379 citations · Full text

, , +14

Resistance to PARP inhibitors by SLFN11 inactivation can be overcome by ATR inhibition

Junko Murai, Ying Feng, Guoying Karen Yu et al. · Oncotarget · 2016 · 292 citations · Full text

, , +13

Trapping Poly(ADP-Ribose) Polymerase

Yuqiao Shen, Mika Aoyagi-Scharber, Bing Wang · Journal of Pharmacology and Experimental Therapeutics · 2015 · 231 citations

, , +15

Dynamic variations in epithelial-to-mesenchymal transition (EMT), ATM, and SLFN11 govern response to PARP inhibitors and cisplatin in small cell lung cancer

C. Allison Stewart, Pan Tong, Robert J. Cardnell et al. · Oncotarget · 2017 · 227 citations · Full text

, , +17

1–5 of 32